Myasthenia Gravis Insights

Early MG Diagnosis Key to Treatment Outcomes

Top Stories

Latest Research

A recent study by Han et al.

(2025)
aims to predict which patients with myasthenia gravis might not respond well to standard treatments early in their diagnosis.

The goal is to identify refractory cases within the first year, as current methods often take years to confirm treatment resistance.

Early prediction could enable doctors to explore alternative therapies sooner, potentially improving outcomes.

By focusing on timely intervention, this approach may lead to better disease management strategies and quality of life for refractory patients.

The study highlights the need for early identification to optimize treatment plans and reduce delays in effective care (Han et al., 2025).

Clinical Trials

This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks:
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Study Type
Phase III
Location
17 countries
Age Range
18+ Years
Enrollment
196
Evaluation of Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of Ravulizumab Administered Intravenously in Pediatric Participants With Generalized Myasthenia Gravis (gMG)
Study Type
Phase III
Location
8 countries
Age Range
0 - Not specified
Enrollment
12
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Study Type
Observational
Location
6 countries
Age Range
18+ Years
Enrollment
500
A Prospective Natural History and Outcome Measure Validation Study of Congenital Myasthenic Syndromes
Study Type
Observational
Location
Maryland
Age Range
6 Months - 99 Years
Enrollment
75

Community News

MG Foundation of America, IncMG Foundation of America, IncApr 27, 2025

Melissa, who is a nurse and lives with MG, shares her perspective in this MGFA blog post:

https://myasthenia.org/blog/2022/08/01/managing-mg-a-nurses-perspective/

Myasthenia Gravis AssociationMyasthenia Gravis AssociationApr 29, 2025

🔍 Today is Undiagnosed Day

Each year, thousands live with unexplained symptoms, searching for answers and validation. For some, like those eventually diagnosed with myasthenia gravis (MG), the path to diagnosis can be long and isolating.

At the Myasthenia Gravis Association, we stand with the undiagnosed — listening, supporting, and advocating for earlier recognition and access to care. 💚

If you're still searching for answers, you are not alone.

📚 Learn more. Ask questions. Keep going.

📩 Contact us: [email protected]

🌐 Visit: www.mgakc.org

Myasthenia Gravis Association Post
Myasthenia GravisMyasthenia GravisApr 27, 2025

As suddenly as FB locked me out, they let me back - go figure.

Upcoming Events

MAY
01
Coffee meetup for MG community In Person Myasthenia Gravis Association • Kansas City, MO
MAY
03
Community Health Fair on MG In Person MG Foundation of America, Inc • Westborough, MA